Retrovir and Renal impairment - a phase IV clinical study of FDA data
Summary:
Renal impairment is found among people who take Retrovir, especially for people who are male, 50-59 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Retrovir and have Renal impairment. It is created by eHealthMe based on reports of 8,386 people who have side effects when taking Retrovir from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
8,386 people reported to have side effects when taking Retrovir.
Among them, 147 people (1.75%) have Renal impairment.
What is Retrovir?
Retrovir has active ingredients of zidovudine. eHealthMe is studying from 8,389 Retrovir users for its effectiveness, alternative drugs and more.
What is Renal impairment?
Renal impairment (severely reduced kidney function) is found to be associated with 2,654 drugs and 2,332 conditions by eHealthMe.
Number of Retrovir and Renal impairment reports submitted per year:
Time on Retrovir when people have Renal impairment *:
Gender of people who have Renal impairment when taking Retrovir*:
Age of people who have Renal impairment when taking Retrovir *:
Common drugs people take besides Retrovir *:
Common side effects people have besides Renal impairment *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Retrovir and have Renal impairment?
Check whether Renal impairment is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Al-Hamdy RA, "Assessment of electrolytes and HbA1c in type 2 diabetic patients using metformin and evaluation of guidelines obedience regarding renal impairment", J.Thi-Qar Sci., 2015 Jan .
Related studies
How severe was Renal impairment and when was it recovered:
Expand to all the drugs that have ingredients of zidovudine:
Alternative drugs to, pros and cons of Retrovir:
- Retrovir (8,389 reports)
Common Retrovir side effects:
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 623 reports
Browse all side effects of Retrovir:
a b c d e f g h i j k l m n o p q r s t u v w x y zRenal impairment treatments and more:
- Renal impairment (85,016 reports)
COVID vaccines that are related to Renal impairment:
- Renal impairment in Moderna COVID Vaccine
- Renal impairment in Pfizer BioNTech Covid Vaccine
- Renal impairment in Johnson and Johnson Covid Vaccine
Common drugs associated with Renal impairment:
- Trasylol: 5,515 reports
- Furosemide: 5,122 reports
- Aspirin: 4,526 reports
- Lasix: 4,326 reports
- Prednisone: 4,305 reports
- Omeprazole: 4,213 reports
- Amlodipine: 3,903 reports
- Metformin: 3,786 reports
- Prevacid: 3,345 reports
- Nexium: 3,295 reports
All the drugs that are associated with Renal impairment:
- Renal impairment (2,654 drugs)
Common conditions associated with Renal impairment:
- High blood pressure: 6,157 reports
- Hiv infection: 4,189 reports
- Rheumatoid arthritis: 3,303 reports
- Multiple myeloma: 2,866 reports
- Gastroesophageal reflux disease: 2,855 reports
- Diabetes: 2,366 reports
- Pain: 2,349 reports
All the conditions that are associated with Renal impairment:
- Renal impairment (2,332 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on zidovudine (the active ingredients of Retrovir) and Retrovir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hyperuricaemia and Renal Impairment - a second ago
- Donepezil and Renal Impairment - 7 seconds ago
- Peginterferon and Renal Impairment - 7 seconds ago
- Fiasp and Pleural Effusion - 8 seconds ago
- Zaroxolyn and Renal Impairment - 12 seconds ago
- Repatha and Renal Impairment - 15 seconds ago
- Gout and Renal Impairment - 20 seconds ago
- Zoledronic Acid and Renal Impairment - 25 seconds ago
- Butrans and Dry Eyes - 55 seconds ago
- Omeprazole and Serum Sickness - a minute ago